Cobequid puts faith in DNA vaccine

Article Abstract:

Qiagen GmbH, headquartered in Germany, has sold the rights to patents for five DNA vaccines for aquaculture to Cobequid Life Sciences Inc. of Richmond Hill, Ontario, for an undisclosed amount. The purchase will allow Cobequid to develop and market the vaccines under the supervision of its new unit, Progressive Genetics Systems Inc. The deal will also allow the company to enhance its financial performance, according to Gerri Greenham, the firm's president. The aquaculture DNA vaccines makes use of genetic coding to protect the host from diseases.

Comment:

Acquires rights to patents for 5 DNA vaccines for aquaculture from Qiagen GmbH for undisclosed amount

Germany, Facilities & equipment, Biological Product (except Diagnostic) Manufacturing, Biological Products, Ontario, Article, Qiagen GmbH, Cobequid Life Sciences Inc.

---

Biovail snags U.S. firm in cash and stock deal

Article Abstract:

Biovail Corporation International reached a $154 million cash and stock agreement to purchase Fuisz Technologies Ltd of Chantilly, VA. The acquisition will enhance Biovail's research and development staff, budget and product holdings. Fuisz makes rapidly dissolving oral drugs, similar to Biovail's controlled-release pharmaceuticals. Both companies' board of directors have approved the consolidation.

United States, Pharmaceutical Preparation Manufacturing, Pharmaceutical Preparations, Drugs, Biovail Corporation International, Fuisz Technologies Ltd.

---

Similar abstracts:

• Abstracts: Philip Services sells aluminum plants. Centrefund to purchase 10 shopping centres. Centrefund to buy four U.S. malls
• Abstracts: CPL to bid on nursing home beds. Canadian coal producers caught in trade dispute. Royal Host launches hostile takeover bid for CHIP
• Abstracts: WinStar to unveil wireless network. Innovative voice network debuts online today. Shutterfly merges best of digital, film
• Abstracts: GM defends move that led to strike. GM shops suppliers for spare parts
• Abstracts: Bell, AT&T keep flat-rate plan. Newbridge turns profit in quarter

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.